Both TIMP-1 and TIMP-2 had significant diagnostic ability in detecting advanced liver disease but the status of TIMP-1 and TIMP-2, in the algorithm of NAFLD diagnosis, is yet to be established. This evidence concerns the gene TIMP2 and metabolic dysfunction-associated steatotic liver disease.